Go back

We’re boosting the biological performance of fish and shrimp to drive productivity, profitability and sustainability in food production.

Benchmark Holdings is a leading aquaculture biotechnology company. Together we are enabling aquaculture producers to improve their sustainability and profitability by providing products and solutions in genetics, advanced nutrition and health which improve yield, quality and animal welfare

Focussing on salmon, shrimp, bass and bream, Benchmark is present in every major aquaculture market with customers in 70 countries. In 2013, Benchmark was listed on the AIM market of the London Stock Exchange.

Benchmark has a broad portfolio of products including sophisticated genetics which improve yield and disease resistance, advanced nutrition solutions which deliver growth and resilience, and sea lice treatments which are helping to address the biggest biological challenge in salmon production.

Its breakthroughs include the adoption of human cancer cell screening techniques to enable earlier disease identification in aquaculture, reducing waste and antibiotic use.

In 2019, Benchmark received the Aquaculture Innovation Award for CleanTreat, a water purification system that removes medicines from treatment water before releasing it back into the sea.

Find out more.

"Wheatsheaf is an ideal shareholder. Their knowledge of the aquaculture sector has been hugely helpful in focussing our offering."

Trond Williksen

Chief Executive Officer, Benchmark Holdings PLC

Trond Williksen

Chief Executive Officer, Benchmark Holdings PLC

For more information on Wheatsheaf's investment in Benchmark Holdings please contact:

Anthony James

Executive Director

Go back

Published on
19 November 2020

We use necessary cookies to make our site work. We’d also like to set Google Analytics cookies to help us to improve our website by understanding how you use it. They do not collect any personal data. Find out more here.